New Zealand’s largest drug developer and manufacturer, Douglas Pharmaceuticals supplies prescription consumer medicines as well as health and beauty products to a number of international markets.
"Research and development is vital in the pharmaceutical industry.”
It’s also West Auckland’s largest employer with 580 staff based at their Henderson manufacturing site and a further 120 staff in Fiji and 20 in America.
To support the ongoing innovation, over the past five years Douglas Pharmaceuticals has received a series of grants from Callaghan Innovation.
“Research and development is vital in the pharmaceutical industry,” says Chief Financial Officer Kent Durbin.
“The grants from Callaghan, in particular the Growth Grant, have enabled us to take on more risk in our new product development.
“This year our research and development spend will be around $NZ30 million up from $NZ12 million in full-year 2013, the year immediately prior to the Callaghan Growth Grant commencing.”